Lower lymphocyte count [27, 41] and higher CRP [22, 39, 56] in COVID-19 AIS patients are similar to other studies and are associated with a poor prognosis of AIS in COVID-19 [41, 56, 57]. This evidence concerns the gene CRP and androgen insensitivity syndrome.